LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update LENSAR (Nasdaq: LNSR) reported fourth-quarter and full-year 2025 results, highlighting recurring revenue of $46.3 million for the year, a 15% increase versus 2024, and recurring revenue representing 79% of total revenue for both Q4 and FY2025. ALLY installed base reached approximately 200 systems (a 48% increase year-over-year) with a backlog of 13 systems and total combined installed base of ~435 systems, up 13% year-over-year.Worldwide procedure volume rose ~22% in 2025. Q4 total revenue was $16.0 million; net loss was $1.5 million for Q4 2025. Cash and investments totaled $18.0 million at year-end. The company and Alcon executed a termination agreement under which LENSAR will retain a $10.0 million merger deposit.

#LNSR LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

www.stocktitan.net/news/LNSR/lensar-reports...

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement Alcon (SIX/NYSE: ALC) and LENSAR (NASDAQ: LNSR) agreed to terminate their previously announced merger. The companies said the nearly one-year regulatory review and the FTC's opposition made the transaction unattractive to pursue.Alcon cited delay and associated costs and reaffirmed its commitment to advancing cataract surgery technologies.

#ALC #LNSR Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

www.stocktitan.net/news/ALC/alcon-and-lensa...

#LNSR LENSAR® Reports Third Quarter 2025 Results and Provides Business Update

www.stocktitan.net/news/LNSR/lensar-reports...

Leading Indicators, Wednesday August 20, 2025 – Crystal Equity Research

Small-cap stocks with declining money flow, Wed Aug 20th - #UPLD #TACO #SAVA #OSPN #NVNO #MCRI #LNSR #KIDS #JAMF #IRBT #RELI #ZSPC #VLN #WBH #YEXT #AXGN #BXFD #CRIS #DYAI #EXFY #FCEL #GGR #UMA #TFIN #SSTK - More: crystalequityresearch.com/leading-indi... - #smallcap

LENSAR Reports Second Quarter 2025 Results and Provides Business Update LENSAR (NASDAQ:LNSR) reported strong Q2 2025 results, highlighted by significant growth in its ALLY Robotic Cataract Laser Systems business. The company achieved total revenue of $13.9 million, up 10% year-over-year, driven by a 23% increase in worldwide procedure volumes.Key highlights include 18 new ALLY Systems placements in Q2 with an additional 18 systems in backlog. The ALLY installed base grew 107% year-over-year to 165 systems, while the total combined installed base increased 23% to 410 systems. The company's recurring revenue reached 82% of total revenue.LENSAR reported a net loss of $1.8 million ($0.15 per share), improved from a $9.0 million loss in Q2 2024. The company ended the quarter with $20.3 million in cash and investments. Notably, shareholders overwhelmingly approved the proposed merger with Alcon, with over 99% of votes in favor, expected to close by year-end.

#LNSR LENSAR Reports Second Quarter 2025 Results and Provides Business Update

www.stocktitan.net/news/LNSR/lensar-reports...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with improving money flow, Mon Jul 7th - #ZVRA #ZJK #XHG #VIGL #TRS #MDIA #LNSR #KRMD #BTCS #ALLR #OCFT #MUX #MED #AMPX - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Halper Sadeh LLC's Shareholder Investigation: Addressing Potential Securities Law Violations Halper Sadeh LLC, an investor rights law firm, is investigating multiple companies for potential securities law violations affecting shareholders' rights.

Halper Sadeh LLC's Shareholder Investigation: Addressing Potential Securities Law Violations #None #Halper_Sadeh_LLC #LNSR #DNB

LENSAR Reports First Quarter 2025 Results and Provides Business Update LENSAR (NASDAQ: LNSR) reported strong Q1 2025 financial results, with total revenue reaching $14.2 million, a 34% increase from Q1 2024. The company placed 14 ALLY Robotic Laser Cataract Systems during the quarter, with an additional backlog of 24 systems pending installation. The total installed base grew to approximately 395 systems, a 26% year-over-year increase. Worldwide procedure volumes increased by 33%, with LENSAR systems performing about 22% of total U.S. procedures. Despite revenue growth, the company reported a net loss of $27.3 million, largely due to warrant liability changes following a 58% stock price increase. Notably, LENSAR announced a proposed merger with Alcon Research, LLC on March 24, 2025, receiving a $10 million cash deposit.

#LNSR LENSAR Reports First Quarter 2025 Results and Provides Business Update

www.stocktitan.net/news/LNSR/lensar-reports...

Halper Sadeh LLC Conducts Shareholder Investigations for AZEK, LNSR, and DNB Halper Sadeh LLC is probing AZEK, LNSR, and DNB for possible federal securities law violations and breaches of fiduciary duty. Shareholders can take action.

Halper Sadeh LLC Conducts Shareholder Investigations for AZEK, LNSR, and DNB #USA #New_York #Halper_Sadeh #AZEK #LNSR

Halper Sadeh LLC Launches Investigations into AZEK, LNSR, and DNB Shareholder Rights Halper Sadeh LLC is investigating AZEK, LNSR, and DNB for possible violations of federal securities laws, seeking increased shareholder rights and options.

Halper Sadeh LLC Launches Investigations into AZEK, LNSR, and DNB Shareholder Rights #United_States #New_York #AZEK #LNSR #DNB

ALC - Alcon Inc Latest Stock News & Market Updates Explore Alcon Inc., a global eye care innovator offering comprehensive visioncare and surgical solutions with expert precision and advanced technology.

#ALC #LNSR Alcon Agrees to Acquire LENSAR, Inc.

www.stocktitan.net/news/ALC/alcon-agrees-to...

Major Medical Tech Deal: Alcon Acquires Robotic Surgery Pioneer LENSAR for $430M Strategic acquisition of LENSAR's advanced robotic cataract laser system strengthens Alcon's position in the 32M procedure global market. Full deal analysis inside.

#ALC #LNSR Alcon Agrees to Acquire LENSAR, Inc.

www.stocktitan.net/news/ALC/alcon-agrees-to...

Major Medical Tech Deal: Alcon Buys LENSAR at 47% Premium, Eyes $32B Cataract Market Strategic acquisition includes ALLY robotic system, offering up to $430M total value with milestone payments. Expands global reach in 32M annual cataract procedures.

#LNSR Alcon Agrees to Acquire LENSAR, Inc.

www.stocktitan.net/news/LNSR/alcon-agrees-t...

LENSAR's Robotic Cataract Systems Surge 86% - Is This Medical Tech Company Turning the Corner? LENSAR achieves 27% annual revenue growth with accelerating momentum into 2025. Company projects positive Adjusted EBITDA as market share exceeds 20%.

#LNSR LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

www.stocktitan.net/news/LNSR/lensar-reports...

#LNSR LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

www.stocktitan.net/news/LNSR/lensar-to-part...

News; ( NASDAQ: #LNSR ) LENSAR Reports Third Quarter 2024 Results and Provides Business Update

#StockMarket #News

Breaking News: ( NASDAQ: #LNSR ) One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems

#StockMarket #News

News; ( NASDAQ: #LNSR ) LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

#StockMarket #News